Raines Merilee
SEC-identified person · CIK 1023869 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Ocular Therapeutix, INC OCUL | Director | filed 2021–2026 |
| Transmedics Group, Inc. TMDX | Director | filed 2021–2026 |
| Watts Water Technologies INC WTS | Director | filed 2011–2025 |
| Benchmark Electronics INC BHE | Director | filed 2018–2021 |
| Aratana Therapeutics, INC. PETX | Director | filed 2014–2019 |
| Affymetrix INC AFFX | Director | filed 2015–2016 |
| Idexx Laboratories INC /DE IDXX` | Vice President and CFO | filed 2006–2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.